Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Study of IMR-687 in Adults with Sickle Cell Disease
2019-004471-39Phase 2Unknown
- Sponsor
- Imara Therapeutics
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sickle cell disease (SCD) comparing IMR-687 with Placebo (2 arms). Status: unknown.
02
Drugs
tovinontrine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2019-004471-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004471-39.